<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Moore SC</submitter><funding>British Heart Foundation</funding><funding>FIC NIH HHS</funding><funding>Medical Research Council</funding><funding>The Francis Crick Institute</funding><funding>National Institute for Health Research (NIHR)</funding><funding>Wellcome Trust</funding><pagination>191-215.e9</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9933851</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>4(3)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Both infection and vaccination, alone or in combination, generate antibody and T cell responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, the maintenance of such responses-and hence protection from disease-requires careful characterization. In a large prospective study of UK healthcare workers (HCWs) (Protective Immunity from T Cells in Healthcare Workers [PITCH], within the larger SARS-CoV-2 Immunity and Reinfection Evaluation [SIREN] study), we previously observed that prior infection strongly affected subsequent cellular and humoral immunity induced after long and short dosing intervals of BNT162b2 (Pfizer/BioNTech) vaccination.&lt;h4>Methods&lt;/h4>Here, we report longer follow-up of 684 HCWs in this cohort over 6-9 months following two</pubmed_abstract><journal>Med (New York, N.Y.)</journal><pubmed_title>Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens.</pubmed_title><pmcid>PMC9933851</pmcid><funding_grant_id>WT109965MA</funding_grant_id><funding_grant_id>D43 TW009127</funding_grant_id><funding_grant_id>FS/18/52/33808</funding_grant_id><funding_grant_id>MR/W02067X/1</funding_grant_id><funding_grant_id>NIHR203792</funding_grant_id><funding_grant_id>COV19-RECPLAS</funding_grant_id><funding_grant_id>MC_UU_0025/12</funding_grant_id><funding_grant_id>PG/11/116/29288</funding_grant_id><funding_grant_id>110,110Z/15/Z</funding_grant_id><funding_grant_id>205228/Z/16/Z</funding_grant_id><funding_grant_id>NIHR300669</funding_grant_id><funding_grant_id>NIHR200907</funding_grant_id><funding_grant_id>CL-2013-07-005</funding_grant_id><funding_grant_id>COVID-19-RECPLAS</funding_grant_id><funding_grant_id>090532/Z/09/Z</funding_grant_id><funding_grant_id>MR/W020564/1</funding_grant_id><funding_grant_id>CL-2018-13-007</funding_grant_id><funding_grant_id>NF-SI-0617-10139</funding_grant_id><funding_grant_id>211153/Z/18/Z</funding_grant_id><funding_grant_id>MR/X001598/1</funding_grant_id><funding_grant_id>204721/Z/16/Z</funding_grant_id><funding_grant_id>PG/11/116/29,288</funding_grant_id><funding_grant_id>110110/Z/15/Z</funding_grant_id><funding_grant_id>MR/X009297/1</funding_grant_id><funding_grant_id>NIHR300791</funding_grant_id><funding_grant_id>CC2223</funding_grant_id><funding_grant_id>110058/Z/15/Z</funding_grant_id><pubmed_authors>Dobson SL</pubmed_authors><pubmed_authors>Brown A</pubmed_authors><pubmed_authors>Tyerman JK</pubmed_authors><pubmed_authors>Newman TAH</pubmed_authors><pubmed_authors>Longet S</pubmed_authors><pubmed_authors>Carroll M</pubmed_authors><pubmed_authors>Wilson JD</pubmed_authors><pubmed_authors>Pollard AJ</pubmed_authors><pubmed_authors>Nicols AR</pubmed_authors><pubmed_authors>Meardon N</pubmed_authors><pubmed_authors>Zhang P</pubmed_authors><pubmed_authors>Deeks AS</pubmed_authors><pubmed_authors>Al-Taei S</pubmed_authors><pubmed_authors>Grouneva I</pubmed_authors><pubmed_authors>Abraham P</pubmed_authors><pubmed_authors>Supasa P</pubmed_authors><pubmed_authors>de Silva TI</pubmed_authors><pubmed_authors>Booth LH</pubmed_authors><pubmed_authors>Klenerman P</pubmed_authors><pubmed_authors>Plowright M</pubmed_authors><pubmed_authors>Dold C</pubmed_authors><pubmed_authors>Lambe T</pubmed_authors><pubmed_authors>Screaton G</pubmed_authors><pubmed_authors>Murray SM</pubmed_authors><pubmed_authors>Hall V</pubmed_authors><pubmed_authors>Tipton T</pubmed_authors><pubmed_authors>Jeffery K</pubmed_authors><pubmed_authors>Turtle L</pubmed_authors><pubmed_authors>Hering LM</pubmed_authors><pubmed_authors>Stafford L</pubmed_authors><pubmed_authors>Bibi S</pubmed_authors><pubmed_authors>Adele S</pubmed_authors><pubmed_authors>Angyal A</pubmed_authors><pubmed_authors>Shields A</pubmed_authors><pubmed_authors>Barnes E</pubmed_authors><pubmed_authors>Rowland-Jones SL</pubmed_authors><pubmed_authors>Dejnirattisai W</pubmed_authors><pubmed_authors>Neale I</pubmed_authors><pubmed_authors>Reyes LS</pubmed_authors><pubmed_authors>Tuekprakhon A</pubmed_authors><pubmed_authors>Kronsteiner B</pubmed_authors><pubmed_authors>Horner EC</pubmed_authors><pubmed_authors>Hornsby H</pubmed_authors><pubmed_authors>Nell JM</pubmed_authors><pubmed_authors>Mongkolsapaya J</pubmed_authors><pubmed_authors>Hopkins S</pubmed_authors><pubmed_authors>Conlon CP</pubmed_authors><pubmed_authors>Faustini S</pubmed_authors><pubmed_authors>Wootton DG</pubmed_authors><pubmed_authors>Duncan CJA</pubmed_authors><pubmed_authors>Richter A</pubmed_authors><pubmed_authors>Cross A</pubmed_authors><pubmed_authors>Mentzer AJ</pubmed_authors><pubmed_authors>Zewdie M</pubmed_authors><pubmed_authors>Phillips E</pubmed_authors><pubmed_authors>Thaventhiran JED</pubmed_authors><pubmed_authors>Ali M</pubmed_authors><pubmed_authors>Matthews PC</pubmed_authors><pubmed_authors>Payne RP</pubmed_authors><pubmed_authors>Malone T</pubmed_authors><pubmed_authors>Dunachie S</pubmed_authors><pubmed_authors>Liu C</pubmed_authors><pubmed_authors>PITCH Consortium</pubmed_authors><pubmed_authors>Moore SC</pubmed_authors><pubmed_authors>Brown R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens.</name><description>&lt;h4>Background&lt;/h4>Both infection and vaccination, alone or in combination, generate antibody and T cell responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, the maintenance of such responses-and hence protection from disease-requires careful characterization. In a large prospective study of UK healthcare workers (HCWs) (Protective Immunity from T Cells in Healthcare Workers [PITCH], within the larger SARS-CoV-2 Immunity and Reinfection Evaluation [SIREN] study), we previously observed that prior infection strongly affected subsequent cellular and humoral immunity induced after long and short dosing intervals of BNT162b2 (Pfizer/BioNTech) vaccination.&lt;h4>Methods&lt;/h4>Here, we report longer follow-up of 684 HCWs in this cohort over 6-9 months following two</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Mar</publication><modification>2026-05-28T10:47:33.344Z</modification><creation>2024-11-09T21:37:04.894Z</creation></dates><accession>S-EPMC9933851</accession><cross_references><pubmed>36863347</pubmed><doi>10.1016/j.medj.2023.02.004</doi></cross_references></HashMap>